The REMAP-CAP study, led by Imperial College London and supported by the NIHR Imperial Biomedical Research Centre, has been named joint Critical Care Team of the Year at the BMJ Awards 2021.
The Critical Care Team of the Year Award recognises teams who have used innovative approaches to deliver safe patient-centred care to critically ill patients. Due to the high standard of finalists this year, two teams were jointly recognised: Imperial College London for REMAP-CAP and NHS England South West for Retrieve Adult Critical Care Transfer Service.
REMAP-CAP is an international, adaptive platform trial led by Imperial and the Intensive Care National Audit & Research Centre (ICNARC) in the UK, and University Medical Center Utrecht in Europe.
The trial has evaluated over 16 different treatments and has delivered some of the most important treatments for COVID-19. In January 2021, the trial showed the effectiveness of the interleukin-6 inhibitors tocilizumab and sarilumab for treating patients with severe COVID-19.
More information and the full story by Ellyw Evans, can be found here © Imperial College London